ArticleFrontiers in oncology2021

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells.

Baocheng Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.